LOW PLASMA GLUTAMINE IN COMBINATION WITH HIGH GLUTAMATE LEVELS INDICATE RISK FOR LOSS OF BODY CELL MASS IN HEALTHY-INDIVIDUALS - THE EFFECTOF N-ACETYL-CYSTEINE
R. Kinscherf et al., LOW PLASMA GLUTAMINE IN COMBINATION WITH HIGH GLUTAMATE LEVELS INDICATE RISK FOR LOSS OF BODY CELL MASS IN HEALTHY-INDIVIDUALS - THE EFFECTOF N-ACETYL-CYSTEINE, Journal of molecular medicine, 74(7), 1996, pp. 393-400
Citations number
51
Categorie Soggetti
Medical Laboratory Technology","Genetics & Heredity
Skeletal muscle catabolism, low plasma glutamine, and high venous glut
amate levels are common among patients with cancer or human immunodefi
ciency virus infection. In addition, a high glycolytic activity is com
monly found in muscle tissue of cachectic cancer patients, suggesting
insufficient mitochondrial energy metabolism. We therefore investigate
d (a) whether an ''anaerobic physical exercise'' program causes simila
r changes in plasma amino acid levels, and (b) whether low plasma glut
amine or high glutamate levels are risk factors for loss of body cell
mass (BCM) in healthy human subjects, i.e., in the absence of a tumor
or virus infection. Longitudinal measurements from healthy subjects ov
er longer periods suggest that the age-related loss of BCM occur mainl
y during episodes with high venous glutamate levels, indicative of dec
reased muscular transport activity for glutamate. A significant increa
se in venous glutamate levels from 25 to about 40 mu M was seen after
a program of ''anaerobic physical exercise.'' This was associated with
changes in T lymphocyte numbers. Under these conditions persons with
low baseline levels of plasma glutamine, arginine, and cystine levels
also showed a loss of BCM. This loss of BCM was correlated not only wi
th the amino acid levels at baseline examination, but also with an inc
rease in plasma glutamine, arginine, and cystine levels during the obs
ervation period, suggesting that a loss of BCM in healthy individuals
terminates itself by adjusting these amino acids to higher levels that
stabilize BCM. To test a possible regulatory role of cysteine in this
context we determined the effect of N-acetyl-cysteine on BCM in a gro
up of subjects with relatively low glutamine levels. The placebo group
of this study showed a loss of BCM and an increase in body fat, sugge
sting that body protein had been converted into other forms of chemica
l energy. The decrease in mean BCM/body fat ratios was prevented by N-
acetyl-cysteine, indicating that cysteine indeed plays a regulatory ro
le in the physiological control of BCM.